XML 14 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Nov. 02, 2024
Oct. 28, 2023
Cash flows from operating activities:    
Net income $ 4,371 $ 22,620
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of deferred debt issuance costs 57 57
Loss on retirement plan terminations 0 4,231
Gain from the sale of equipment (11) (136)
Depreciation and amortization 10,232 10,338
Deferred taxes, net of valuation allowance 1,924 9,232
Stock compensation expense 2,288 1,615
Board of directors' stock compensation 335 332
Changes in operating assets and liabilities:    
Accounts receivable 2,825 (1,994)
Inventories (8,171) (6,854)
Prepaid expenses and other current assets 989 (118)
Other assets (103) 55
Accounts payable 10,660 708
Operating leases, net (3,109) 548
Accrued expenses and other liabilities (9,832) (7,533)
Net cash provided by operating activities 12,455 33,101
Cash flows from investing activities:    
Additions to property and equipment, net (19,405) (10,404)
Proceeds from sale of equipment 11 136
Purchase of short-term investments (39,012) (69,880)
Maturity of short-term investments 35,875 21,007
Net cash used for investing activities (22,531) (59,141)
Cash flows from financing activities:    
Repurchase of common stock, excluding excise taxes (10,421) (14,850)
Tax withholdings paid related to net share settlements (65) (758)
Proceeds from the exercise of stock options 80 297
Net cash used for financing activities (10,406) (15,311)
Net decrease in cash and cash equivalents (20,482) (41,351)
Cash and cash equivalents:    
Beginning of period 27,590 52,074
End of period 7,108 10,723
Supplemental Disclosures of Cash Flow Information:    
Cash paid during the period for income taxes 1,015 453
Cash paid during the period for interest 288 250
Non-cash activity during the period:    
Capital expenditures incurred but not yet paid $ 1,916 $ 1,588